Locations:
Search IconSearch

New App Shows Patients Individualized Health Risks, With and Without Bariatric Surgery

Predictive tool should help in treatment decisions

19-DDI-5505 Bariatric Risk Calculator 650×450

Despite solid research showing that bariatric surgery significantly improves outcomes for patients with obesity and Type 2 diabetes, with benefits including reduced cardiovascular morbidity and mortality, few eligible patients choose to undergo weight-loss surgery.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

But that situation may soon be shifting, thanks to a new personalized risk calculator developed by Cleveland Clinic researchers, who introduced the predictive tool at the Obesity Week 2019 international conference.

“Our calculator lets every patient see for him- or herself their own individualized estimates for events including risk of dying, heart attack, stroke, diabetic kidney disease, and heart failure over the next 10 years,” says Digestive Disease & Surgery Institute bariatric surgeon Ali Aminian, MD. “The calculator allows patients with Type 2 diabetes to understand in a personal way how the risks and benefits of surgery compare to medical management. It could be a game-changer.”

Until now, when physicians discussed risks and benefits with patients choosing between standard medical management and weight-loss surgery, they could only offer estimates based on outcomes for large, anonymous groups. The new calculator changes that.

Its predictions for a particular patient are based on data points describing that patient’s degree of obesity, severity of diabetes, and specific cardiovascular risk factors. Using 26 such variables, the machine-learning algorithms calculate the 10-year risk of mortality, heart attack, stroke, heart failure, and diabetic kidney disease for that individual.

May help break down barriers

“A patient can see, for example, that their risk of dying in 10 years would be 7% without the surgery, but with the surgery it would drop to 2%,” says Dr. Aminian, “They can understand the risks and benefits in a way that they couldn’t see before.”

Advertisement

“In the past few years, bariatric surgical procedures have been included in the evidence-based guidelines for management of diabetes in patients with obesity,” says Dr. Aminian. Nonetheless, only 1% of patients eligible for surgical weight-loss procedures have actually undergone them, he explains.

Part of the problem, he says, is that patients lack insurance or that insurers won’t reliably cover the costs. “Another issue, though, is patients not knowing the benefits of the operations,” he says.

A two-part development process

Dr. Aminian and his team developed the risk score calculator in two phases over the course of about two years. The researchers used data drawn from about 14,000 Cleveland Clinic patients with obesity and Type 2 diabetes. A subset of nearly 2,300 underwent bariatric surgery.

“In part one of our work, we showed that bariatric surgery was associated with significant reductions in cardiovascular morbidity and mortality,” he says. Specifically, the 8-year risk of death proved to be 18% for those patients who underwent standard medical management for their diabetes, while for patients who had weight-loss surgery, the risk of death was about 10%.

In September, Dr. Aminian and his research partners presented their part-one findings at the European Society of Cardiology Congress as late-breaking research, which was simultaneously published in JAMA.

“In part two, we went a step further,” Dr. Aminian says. “Using machine-learning algorithms, we identified 26 risk factors for the different outcomes, including risk of dying, in that large group of patients. Based on those risk factors, we created the formulae we needed to develop the calculator.”

Advertisement

The area under the curve of the calculator’s prediction models ranged from 0.66 to 0.81 (1=perfect discrimination, 0.5=chance), with the best discrimination ability for all-cause mortality.

The team’s results were presented as one of the Top 10 studies at the Obesity Week 2019 Congress.

A readily available tool

The risk score calculator will be available to physicians and patients on two different platforms, beginning in November 2019:

The calculator also will be accessible on the website of the American Society for Metabolic and Bariatric Surgery in late 2019. “The society wants to promote this useful, evidence-based tool,” says Dr. Aminian. “They are going to have a page on their website devoted to making the decision between routine medical treatment versus surgery for Type 2 diabetes and they will offer our new tool.”

Since bariatric surgery results in better health outcomes and longer lives for patients with Type 2 diabetes compared with medical management, Dr. Aminian hopes the risk calculator will prompt more of them to choose surgery. “We look forward to this tool having the power to change patients’ perspectives,” he says.

Advertisement

Related Articles

Illustration of J pouch
May 21, 2026/Digestive/Research

Ulcerative Colitis Patients with Pyoderma Gangrenosum Have Worse Outcomes with J-Pouch Surgery, Study Finds

Patients have a significantly higher risk of developing fistulas and experiencing future Crohn’s-like changes

Dr. Gorgun in operating room
May 20, 2026/Digestive/Research

Cleveland Clinic Colorectal Surgeons Develop a New Standardized Endoscopic Grading System for Rectal Cancer Response and Organ Preservation

Cleveland Clinic researchers developed an objective tool to assess response following total neoadjuvant therapy.

Patient speaking with physicians
May 11, 2026/Digestive/Research

Adherence to Lifestyle Changes Peaks One Month After Bariatric Surgery, Study Finds

Patients may benefit from booster appointments, psychological support

Dr. Aminian in OR
May 7, 2026/Digestive/Research

Metabolic Surgery May Reverse MASH Cirrhosis, Paired Biopsy Study Suggests

Research demonstrates cirrhosis regression in one-third of patients, with higher rates using alternative assessment

Dr. Regueiro speaking with patient
May 6, 2026/Digestive/Research

Patients With IBD Who Undergo Colon Cancer Surgery Have Higher Blood Clot Risk

Elevated risk persists for more than a year after surgery, plus more insights from the first study to quantify risk specifically for CRC surgery

Pharmacist filling order
May 5, 2026/Digestive/Research

Fenofibrate-UDCA Combination Therapy Safe and Effective for Primary Biliary Cholangitis

Large, retrospective study indicates improved outcomes after one and five years of treatment

Dr. Bhatt with clinician
April 28, 2026/Digestive/Innovation

Endorobotics Collaborative: A New Era in Gastrointestinal Procedures

Multidisciplinary collaboration is fueling breakthroughs in endoscopic and surgical technology

Dr. Kwan and Dr. Hashimoto performing Laparoscopic Liver Transplant Surgery
April 9, 2026/Digestive/Transplant

Transforming Liver Transplantation at Cleveland Clinic

A surge in transplants, advanced surgical techniques and multidisciplinary collaboration has helped shape and expand the Liver Transplant Program

Ad